Effects of Functional Electrical Stimulation on Spasticity, Quadriceps Muscle Strength and Functional Mobility in Individuals With Paraplegia (FES-PAR-RCT)
Effects of Functional Electrical Stimulation on Spasticity, Quadriceps Muscle Strength and Functional Mobility in Individuals With Paraplegia: A Randomized Controlled Trial
Spinal cord injury (SCI)-related paraplegia is a complex neurological condition characterized by motor impairment, increased spasticity, and significant functional limitations in daily activities. Spasticity is one of the most common secondary complications after upper motor neuron lesions and can negatively affect rehabilitation outcomes, gait ability, and functional independence.
This randomized controlled study aims to investigate the effects of Functional Electrical Stimulation (FES) applied to the quadriceps muscle in individuals with paraplegia. Participants will be randomly assigned to either a control group receiving conventional neurorehabilitation or an intervention group receiving additional FES treatment.
The primary outcomes include changes in spasticity level, quadriceps muscle strength, and functional mobility. Spasticity will be assessed using the Modified Ashworth Scale (MAS), muscle strength will be evaluated with Manual Muscle Testing (MMT), and functional mobility will be measured using the Spinal Cord Independence Measure (SCIM), Timed Up and Go Test (TUG), and 6-Minute Walk Test (6MWT).
The intervention period will last 8 weeks, with standardized rehabilitation programs applied to both groups. The FES group will additionally receive quadriceps stimulation with specific neuromuscular electrical stimulation parameters.
The findings of this study are expected to provide evidence regarding the effectiveness of FES as an adjunct to conventional rehabilitation in improving motor function and functional independence in individuals with paraplegia.
調査の概要
状態
条件
詳細な説明
Spinal cord injury (SCI) is a major cause of long-term disability worldwide, often resulting in paraplegia when the thoracic, lumbar, or sacral spinal segments are affected. Individuals with paraplegia commonly experience significant impairments in voluntary motor control, muscle weakness, spasticity, and reduced functional mobility, all of which contribute to decreased independence in activities of daily living.
Spasticity, defined as a velocity-dependent increase in muscle tone due to hyperexcitability of the stretch reflex, is one of the most frequent complications following upper motor neuron lesions. Although spasticity may occasionally contribute to functional stability, excessive spasticity often interferes with voluntary movement, gait training, and rehabilitation outcomes (Pandyan et al., 2005).
Functional Electrical Stimulation (FES) is a neurorehabilitation technique that delivers electrical impulses to peripheral nerves to evoke functional muscle contractions. It facilitates neuromuscular re-education, enhances motor unit recruitment, and may promote neuroplasticity in the central nervous system. Previous studies have demonstrated that FES can improve muscle strength, walking ability, and functional independence in individuals with neurological impairments (Sheffler & Chae, 2007; Kesar et al., 2010; Hesse et al., 2003).
This study is designed as a prospective, single-center, parallel-group, randomized controlled trial conducted in accordance with CONSORT 2010 guidelines. A total of 60 participants with paraplegia secondary to spinal cord injury will be enrolled and randomly allocated into two groups:
Control Group: Standard neurorehabilitation program only Intervention Group: Standard neurorehabilitation program + FES applied to the quadriceps femoris muscle The rehabilitation program will be conducted 3 days per week for 8 weeks and will include stretching exercises, strengthening exercises, balance training, and transfer training. In the intervention group, FES will be applied 5 days per week for 8 weeks with the following parameters: 35 Hz frequency, 300 µs pulse duration, and 10 seconds on / 20 seconds off cycle.
Outcome assessments will be performed at baseline (week 0) and after intervention (week 8). Spasticity will be evaluated using the Modified Ashworth Scale (MAS), which is widely used in clinical practice for assessing muscle tone in neurological conditions. Quadriceps muscle strength will be measured using Manual Muscle Testing (MMT) based on the Medical Research Council (MRC) scale. Functional mobility and independence will be assessed using SCIM, TUG, and 6MWT.
SCIM is a validated scale specifically developed for individuals with spinal cord injury and assesses self-care, respiration and sphincter management, and mobility domains. TUG test provides an objective measure of functional mobility and fall risk, while 6MWT evaluates functional exercise capacity and endurance.
The primary hypothesis of this study is that FES combined with conventional rehabilitation will significantly reduce spasticity, improve quadriceps muscle strength, and enhance functional mobility compared to conventional rehabilitation alone.
The results of this study are expected to contribute to the evidence base regarding the clinical effectiveness of FES in neurorehabilitation and may support its integration into standard rehabilitation protocols for individuals with paraplegia.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Mehmet Salih TAN, Doctorate
- 電話番号:+905467266876
- メール:mstan@medipol.edu.tr
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Participants will be included in the study if they meet all of the following criteria:
- Aged between 18 and 65 years
- Diagnosed with spinal cord injury resulting in paraplegia (traumatic or non-traumatic etiology)
- Classified as ASIA Impairment Scale C or D
- Medically stable condition
- Presence of lower extremity spasticity (Modified Ashworth Scale ≥ 1)
- Ability to understand and follow simple instructions
- Willingness to participate and provide informed consent
Exclusion Criteria:
- Participants will be excluded if they present any of the following conditions:
- Presence of cardiac pacemaker or implanted electrical device
- Severe cognitive impairment or communication difficulties preventing participation
- Active infection or systemic inflammatory condition
- Severe lower extremity contractures or deformities limiting movement
- Dermatological conditions or open wounds preventing FES application
- History of severe autonomic dysreflexia triggered by electrical stimulation
- Uncontrolled medical conditions that may interfere with participation or safety
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Control Group - Conventional Rehabilitation
Participants in this arm will receive a standard neurorehabilitation program for paraplegia secondary to spinal cord injury.
The program will include stretching exercises, progressive strengthening exercises, balance training, and transfer training.
Sessions will be conducted 3 days per week, 45-60 minutes per session, for a total duration of 8 weeks.
No Functional Electrical Stimulation (FES) will be applied in this group.
|
This intervention consists of a conventional neurorehabilitation program designed for individuals with paraplegia secondary to spinal cord injury.
The program includes stretching exercises, progressive strengthening exercises, balance training, and transfer training.
Sessions are conducted 3 days per week, 45-60 minutes per session, over a total duration of 8 weeks.
This group does not receive Functional Electrical Stimulation (FES).
The intervention is aimed at improving general motor function, maintaining joint range of motion, and enhancing functional independence.
|
|
実験的:FES + Conventional Rehabilitation Group
Participants in this arm will receive the same standard neurorehabilitation program as the control group, including stretching, strengthening, balance, and transfer training (3 days per week, 45-60 minutes per session for 8 weeks).
In addition, Functional Electrical Stimulation (FES) will be applied to the quadriceps femoris muscle.
FES parameters will include 35 Hz frequency, 300 µs pulse duration, and a 10-second on / 20-second off cycle.
FES will be administered 5 days per week for 8 weeks to facilitate neuromuscular activation, improve muscle strength, and reduce spasticity.
|
This intervention consists of Functional Electrical Stimulation (FES) applied to the quadriceps femoris muscle in addition to the same conventional neurorehabilitation program provided to the control group.
FES is delivered using a neuromuscular electrical stimulation device to induce muscle contractions via peripheral nerve activation.
Stimulation parameters include 35 Hz frequency, 300 µs pulse duration, and a 10-second on / 20-second off cycle.
The intervention is applied 5 days per week for 8 weeks.
The aim is to enhance neuromuscular activation, reduce spasticity, increase quadriceps muscle strength, and improve functional mobility in individuals with paraplegia.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Spasticity Level
時間枠:Baseline and Week 8
|
Spasticity will be assessed using the Modified Ashworth Scale (MAS), which grades muscle tone from 0 to 4. Higher scores indicate increased spasticity.
The primary comparison will be the change in MAS scores between baseline and after 8 weeks of intervention.
|
Baseline and Week 8
|
|
Quadriceps Muscle Strength
時間枠:Baseline and Week 8
|
Muscle strength will be evaluated using Manual Muscle Testing (MMT) based on the Medical Research Council (MRC) scale (0-5).
Higher scores indicate greater muscle strength.
|
Baseline and Week 8
|
|
Functional Mobility
時間枠:Baseline and Week 8
|
Functional mobility will be assessed using: Spinal Cord Independence Measure (SCIM) Timed Up and Go Test (TUG) 6-Minute Walk Test (6MWT) SCIM evaluates independence in daily activities, TUG assesses functional mobility and fall risk, and 6MWT measures walking capacity and endurance. Improvements indicate better functional mobility. |
Baseline and Week 8
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Functional Independence (SCIM subdomains)
時間枠:Baseline and Week 8
|
Changes in self-care, respiration/sphincter management, and mobility domains of SCIM will be analyzed separately.
|
Baseline and Week 8
|
|
Walking Performance
時間枠:Baseline and Week 8
|
Total distance walked in 6 minutes (meters).
Increased distance indicates improved functional endurance
|
Baseline and Week 8
|
|
Functional Mobility Performance
時間枠:Baseline and Week 8
|
Time required (seconds) to stand up, walk 3 meters, turn, return, and sit down.
Lower time indicates improved mobility.
|
Baseline and Week 8
|
|
Spasticity Severity
時間枠:Baseline and Week 8
|
Comparison of spasticity reduction between intervention and control groups.
|
Baseline and Week 8
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- MPU-FES-2026-05
- MPU-FES-RCT-2026 (その他の識別子:Istanbul Medipol University)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。